Category: Workers Comp

505 posts found

Could Convalescent Plasma Treat COVID-19?

The FDA, JAMA, and others think blood from those who recovered from COVID-19 could benefit those with the illness.

With frontline workers at risk, states are expanding coverage to healthcare workers, first responders, and other frontline workers.

Healthesystems’ VP of Clinical Services discusses population trends, non-opioid pain therapies, and comorbidities with WorkCompWire.

The WCIRB is partnering with workers’ comp organizations across the country

In response to the COVID-19 pandemic, the state issued a delay in adherence.

Will disruptions in manufacturing result in drug shortages?

FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.

COVID-19 drug trials are underway, but the pandemic is disrupting clinical testing.

Cause Code 83 for Pandemic and Nature Code 83 for COVID-19 will impact future reporting for claims impacted by coronavirus.

Healthesystems has created a developments webpage to track updates impacting workers’ comp.

Anjeso and a new Advil formulation target pain, while Nurtec™ and Vyepti™ target migraines.

Healthesystems collaborated with Risk & Insurance to survey 669 workers’ comp professionals on top trends and challenges.

A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.

Several state workers’ comp programs are relaxing telehealth rules to promote social distancing.

Healthesystems’ AVP of Advocacy & Compliance discusses industry challenges, special initiatives, and more in a video spotlight.

Prev 1 2 3 4 5 … 23 24 25 26 27 … 30 31 32 33 34 Next